1. α-Synuclein binds to the ER–mitochondria tethering protein VAPB to disrupt Ca2+ homeostasis and mitochondrial ATP production
   Sébastien Paillusson et al, 2017, Acta Neuropathol CrossRef
2. Review on the Effect of Resveratrol on Central Nervous System Disease
   Wenzhe Dong et al, 2016, JBBS CrossRef
3. Resveratrol: A Focus on Several Neurodegenerative Diseases
   Ester Tellone et al, 2015, Oxidative Medicine and Cellular Longevity CrossRef
4. null
   Gin S. Malhi et al, 2017 CrossRef
5. Prenatal alcohol exposure alters p35, CDK5 and GSK3β in the medial frontal cortex and hippocampus of adolescent mice
   Samantha L. Goggin et al, 2014, Toxicology Reports CrossRef
6. Guanosine exerts neuroprotective effects by reversing mitochondrial dysfunction in a cellular model of Parkinson's disease.
   Da-Wei Li et al, 2014, Int. J. Mol. Med. CrossRef
7. Substance P prevents 1-methyl-4-phenylpyridiniuminduced cytotoxicity through inhibition of apoptosis via neurokinin-1 receptors in MES23.5 cells
   SHUANG-YAN WANG et al, 2015 CrossRef
8. Cilostazol Mediated Nurr1 and Autophagy Enhancement: Neuroprotective Activity in Rat Rotenone PD Model
   Shireen A. Hedya et al, 2018, Mol Neurobiol CrossRef
9. Mapping the protein phosphorylation sites in human mitochondrial complex I (NADH: ubiquinone oxidoreductase): A bioinformatics study with implications for brain aging and neurodegeneration
   Niya Gowthami et al, 2018, Journal of Chemical Neuroanatomy CrossRef
10. Adenosine N1-Oxide Exerts Anti-inflammatory Effects through the PI3K/Akt/GSK-3β Signaling Pathway and Promotes Osteogenic and Adipocyte Differentiation
    Emiko Ohashi et al, 2019, Biological & Pharmaceutical Bulletin CrossRef
11. The inhibition of BDNF/TrkB/PI3K/Akt signal mediated by AG1601 promotes apoptosis in malignant glioma
    Hongqiang Yin et al, 2019, J Cell Biochem CrossRef
12. Dock GEFs and their therapeutic potential: Neuroprotection and axon regeneration
    Kazuhiko Namekata et al, 2014, Progress in Retinal and Eye Research CrossRef
13. Chronic over-nutrition and dysregulation of GSK3 in diseases
    Xunxian Liu et al, 2016, Nutr Metab (Lond) CrossRef
14. Neuroprotective Effects of Salidroside in the MPTP Mouse Model of Parkinson’s Disease: Involvement of the PI3K/Akt/GSK3βPathway
    Wei Zhang et al, 2016, Parkinson's Disease CrossRef
15. Modulation of AβPP and GSK3β by Endoplasmic Reticulum Stress and Involvement in Alzheimer’s Disease
    Xin-jun Liu et al, 2017, JAD CrossRef
16. Use of a special Brazilian red-light emitting railroad worm Luciferase in bioassays of NEK7 protein Kinase and Creatine Kinase
    Arina Marina Perez et al, 2017, BMC Biochem CrossRef
17. Gsk3β and Tomm20 are substrates of the SCFFbxo7/PARK15 ubiquitin ligase associated with Parkinson's disease
    Felipe Roberti Teixeira et al, 2016 CrossRef
18. Structural characterization of a safflower polysaccharide and its promotion effect on steroid-induced osteonecrosis in vivo
    Daping Cui et al, 2020, Carbohydrate Polymers CrossRef
19. A dual druggable genome-wide siRNA and compound library screening approach identifies modulators of parkin recruitment to mitochondria
    Helen L. Scott et al, 2020, J. Biol. Chem. CrossRef
20. Glycogen synthase kinase-3 as a key regulator of cognitive function
    Xuhong Fan et al, 2020 CrossRef
21. Meridianins and Lignarenone B as Potential GSK3β Inhibitors and Inductors of Structural Neuronal Plasticity
    Laura Llorach-Pares et al, 2020, Biomolecules CrossRef
22. Eupatilin prevents behavioral deficits and dopaminergic neuron degeneration in a Parkinson's disease mouse model
    Yuan Zhang et al, 2020, Life Sciences CrossRef
23. Neuroprotective Effect of Chlorogenic Acid on Mitochondrial Dysfunction-Mediated Apoptotic Death of DA Neurons in a Parkinsonian Mouse Model
    Saumitra Sen Singh et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
24. Histone deacetylase-3: Friend and foe of the brain
    Santosh R D’Mello, 2020, Exp Biol Med (Maywood) CrossRef
25. Modulated Expression of the Protein Kinase GSK3 in Motor and Dopaminergic Neurons Increases Female Lifespan in Drosophila melanogaster
    Mikhail V. Trostnikov et al, 2020, Front. Genet. CrossRef
26. Paeonol exerts anti‑tumor activity against colorectal cancer cells by inducing G0/G1 phase arrest and cell apoptosis via inhibiting the Wnt/β‑catenin signaling pathway
    Li‑Hua Liu et al, 2020, Int J Mol Med CrossRef
27. Salidroside inhibits steroid-induced avascular necrosis of the femoral head via the PI3K/Akt signaling pathway: In�vitro and in�vivo studies
    Xing‑He Xue et al, 2017, Mol Med Report CrossRef
28. Damage to dopaminergic neurons by oxidative stress in Parkinson's disease (Review).
    Ji-Dong Guo et al, 2018, Int J Mol Med CrossRef
29. Allicin inhibits osteoblast apoptosis and steroid-induced necrosis of femoral head progression by activating the PI3K/AKT pathway
    Jingdi Zhan et al, 2020, Food Funct. CrossRef
30. Squaramides as Bioisosteres in Contemporary Drug Design
    Kylie A. Agnew-Francis et al, 2020, Chem. Rev. CrossRef
31. Recent Advances on the Role of GSK3β in the Pathogenesis of Amyotrophic Lateral Sclerosis
    Hyun-Jun Choi et al, 2020, Brain Sciences CrossRef
32. Tantalizing role of p53 molecular pathways and its coherent medications in neurodegenerative diseases
    Marjan Talebi et al, 2021, International Journal of Biological Macromolecules CrossRef
33. Interaction between Parkin and α-Synuclein in PARK2-Mediated Parkinson’s Disease
    Daniel Aghaie Madsen et al, 2021, Cells CrossRef
34. Traumatic Brain Injury: Mechanistic Insight on Pathophysiology and Potential Therapeutic Targets.
    Komal Thapa et al, 2021, J Mol Neurosci CrossRef
35. α-Synuclein Induces the GSK-3-Mediated Phosphorylation and Degradation of NURR1 and Loss of Dopaminergic Hallmarks
    Ángel Juan García-Yagüe et al, 2021, Mol Neurobiol CrossRef
36. FUS-induced neurotoxicity is prevented by inhibiting GSK-3β in a Drosophila model of amyotrophic lateral sclerosis
    Hyun-Jun Choi et al, 2021 CrossRef
37. Brain-Protective Mechanisms of Transcription Factor NRF2: Toward a Common Strategy for Neurodegenerative Diseases
    Antonio Cuadrado, 2022, Annu. Rev. Pharmacol. Toxicol. CrossRef
38. Food Contamination: An Unexplored Possible Link between Dietary Habits and Parkinson’s Disease
    Giulia Caioni et al, 2022, Nutrients CrossRef
39. Emerging targets signaling for inflammation in Parkinson’s disease drug discovery
    Rhema Chandan Khairnar et al, 2022, Metab Brain Dis CrossRef
40. Selective GSK3β Inhibition Mediates an Nrf2-Independent Anti-inflammatory Microglial Response
    Mohamed H. Yousef et al, 2022, Mol Neurobiol CrossRef
41. Evaluating the neuroprotective activities of vinpocetine, punicalagin, niacin and vitamin E against behavioural and motor disabilities of manganese-induced Parkinson's disease in Sprague Dawley rats
    Karema Abu-Elfotuh et al, 2022, Biomedicine & Pharmacotherapy CrossRef
42. Pathogenesis and management of traumatic brain injury (TBI): role of neuroinflammation and anti-inflammatory drugs
    Sunishtha Kalra et al, 2022, Inflammopharmacol CrossRef
43. Influence of heavy metals in Parkinson’s disease: an overview
    Balachandar Vellingiri et al, 2022, J Neurol CrossRef
44. Glycogen Synthase Kinase 3β Involvement in Neuroinflammation and Neurodegenerative Diseases
    Teresa Gianferrara et al, 2022, CMC CrossRef
45. Anti-Parkinsonian effect of Mucuna pruriens and Ursolic acid on GSK3β/Calcium signaling in neuroprotection against Rotenone-induced Parkinsonism
    Walia Zahra et al, 2022, Phytomedicine Plus CrossRef
46. Marine Natural Products from the Russian Pacific as Sources of Drugs for Neurodegenerative Diseases
    Yuri S. Khotimchenko et al, 2022, Marine Drugs CrossRef
47. Structure–Activity Relationship (SAR) Studies on Substituted N-(Pyridin-3-yl)-2-amino-isonicotinamides as Highly Potent and Selective Glycogen Synthase Kinase-3 (GSK-3) Inhibitors
    Guanglin Luo et al, 2023, Bioorganic & Medicinal Chemistry Letters CrossRef